Umeclidinium Bromide Suppliers & Bulk Manufacturers
Available Forms: dry-powder inhaler
Available Strengths: 62.5 mcg
Reference Brands: Incruse Ellipta (USA)
Category: Respiratory Disorder
Umeclidinium bromide is a long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of COPD. By blocking muscarinic receptors (especially M3) in airway smooth muscle, it causes bronchodilation and helps improve airflow. It is given once daily via a dry-powder inhaler, making it convenient for long-term therapy. Clinical trials have shown that it provides sustained lung function improvement and is generally well tolerated, with a low risk of systemic anticholinergic side effects. Umeclidinium Bromide is available in dry-powder inhaler and strengths such as 62.5 mcg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Umeclidinium Bromide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Umeclidinium Bromide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Umeclidinium Bromide is used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It helps improve airflow and reduce breathing difficulties.
Umeclidinium Bromide contains the active ingredient umeclidinium bromide, a long-acting muscarinic antagonist (LAMA), along with standard inhalation excipients depending on the formulation.
The widely known trade name is Incruse Ellipta.
It is manufactured by GlaxoSmithKline (GSK) and also produced by other authorized manufacturers in regulated markets.
The generic name is umeclidinium bromide.
The brand name is Incruse Ellipta.
It is manufactured in various regulated pharmaceutical facilities worldwide, including production sites operated by GlaxoSmithKline and other approved global manufacturers.
Related Products
Ensifentrine
Strength:
3 mg per 2.5 mL
Form: Inhalation solution
Reference Brands: Ohtuvayre (USA)
View Details
Mepolizumab
Strength:
100 mg/1 mL
Form: injection (prefilled syringe)
Reference Brands: Nucala (USA/EU)
View Details
Levalbuterol
Strength:
0.31 mg, 0.63 mg, 1.25 mg
Form: Inhalation solution
Reference Brands: Xopenex (USA/EU)
View Details
Quick Response Guaranteed | Verified Suppliers
